Why the Cardiac Diabetic PCD Franchise Is Your Best Investment
Investing in the cardiac diabetic PCD pharma franchise is not just a wise financial decision; it’s a step towards becoming part of an ever-growing and essential industry. With the rise of lifestyle diseases like diabetes and heart conditions, the demand for specialised medications is at an all-time high. This blog will explain why this franchise model is a golden opportunity and how it taps into a booming market. Post-COVID Growth of the Indian Pharma Industry The Indian pharmaceutical industry has seen explosive growth, especially post-COVID era. According to reports, the sector has grown at a compound annual growth rate (CAGR) of around 11%. India is now the third-largest producer of pharmaceuticals in the world, and its domestic demand continues to skyrocket. The Cardiac Diabetic PCD Pharma Franchise is poised for a thriving market due to the growing demand for drugs addressing chronic diseases like diabetes and cardiovascular conditions. Why Cardiac and Diabetic Segments? Nearly 77